| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Drug ineffective | FAERS: 315 Canada Vigilance: 31 | Canada Vigilance US FAERS | |
| 2 | Acute kidney injury | FAERS: 126 Canada Vigilance: 62 |
1476483
1891032 1934676 2396095 2491533 3341668 3376977 4062110 7632529 7947045 8038467 8416680 8519942 10586837 10615548 11214960 15247861 16270145 16503907 16854507 16987286 17406046 18656262 18755125 20117065 20307148 20862348 | CTD Canada Vigilance US FAERS |
| 3 | Nausea | FAERS: 77 | 7571352 | CTD OFFSIDES SIDER US FAERS |
| 4 | Headache | FAERS: 63 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 5 | Vomiting | FAERS: 60 Canada Vigilance: 1 | 7571352 8322628 | CTD SIDER Canada Vigilance US FAERS |
| 6 | Pharmaceutical product complaint | FAERS: 57 | US FAERS | |
| 7 | Product quality issue | FAERS: 56 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 8 | Pruritus | FAERS: 55 | SIDER US FAERS | |
| 9 | Altered state of consciousness | FAERS: 48 | OFFSIDES SIDER US FAERS | |
| 10 | Dizziness | FAERS: 48 Canada Vigilance: 2 | Canada Vigilance SIDER US FAERS | |
| 11 | Fatigue | FAERS: 44 Canada Vigilance: 2 | 3711686 | CTD OFFSIDES SIDER Canada Vigilance US FAERS |
| 12 | Erythema | FAERS: 41 Canada Vigilance: 3 | Canada Vigilance SIDER US FAERS | |
| 13 | Somnolence | FAERS: 41 | SIDER US FAERS | |
| 14 | Malaise | FAERS: 39 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 15 | Agitation | FAERS: 38 | SIDER US FAERS | |
| 16 | Blood creatinine increased | FAERS: 38 Canada Vigilance: 5 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 17 | Delirium | FAERS: 37 | CTD SIDER US FAERS | |
| 18 | Depressed Level of Consciousness | FAERS: 37 Canada Vigilance: 3 | Canada Vigilance SIDER US FAERS | |
| 19 | Disorientation | FAERS: 36 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 20 | Medication Error | FAERS: 36 | US FAERS | |
| 21 | Urticaria | FAERS: 34 | SIDER US FAERS | |
| 22 | Asthenia | FAERS: 33 | SIDER US FAERS | |
| 23 | Hypersensitivity | FAERS: 32 | SIDER US FAERS | |
| 24 | Overdose | FAERS: 32 | OFFSIDES US FAERS | |
| 25 | Restlessness | FAERS: 32 | US FAERS | |
| 26 | Pathogen resistance | FAERS: 31 | US FAERS | |
| 27 | Dysarthria | FAERS: 30 | 4062110 9496746 14658398 | CTD SIDER US FAERS |
| 28 | Mental status changes | FAERS: 30 | OFFSIDES US FAERS | |
| 29 | Pain | FAERS: 30 Canada Vigilance: 1 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 30 | Abdominal Pain | FAERS: 29 | SIDER US FAERS | |
| 31 | nervous system disorder | FAERS: 29 | SIDER US FAERS | |
| 32 | Product substitution issue | FAERS: 27 | US FAERS | |
| 33 | Tremor | FAERS: 27 | 8671884 | CTD SIDER US FAERS |
| 34 | Aphasia | FAERS: 26 | US FAERS | |
| 35 | Burning sensation | FAERS: 26 | US FAERS | |
| 36 | Drug resistance | FAERS: 24 | US FAERS | |
| 37 | treatment failure | FAERS: 24 | US FAERS | |
| 38 | Drug exposure during pregnancy | FAERS: 21 | US FAERS | |
| 39 | Extravasation | FAERS: 21 | US FAERS | |
| 40 | Toxicity to various agents | FAERS: 21 | US FAERS | |
| 41 | Alopecia | FAERS: 20 Canada Vigilance: 2 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 42 | Encephalitis | FAERS: 19 | 1476483 | CTD US FAERS |
| 43 | Epilepsy | FAERS: 19 | US FAERS | |
| 44 | Myoclonus | FAERS: 19 Canada Vigilance: 2 | 4062110 7571352 7973922 | CTD Canada Vigilance US FAERS |
| 45 | Eye pain | FAERS: 17 | OFFSIDES US FAERS | |
| 46 | Skin lesion | FAERS: 16 Canada Vigilance: 1 | Canada Vigilance OFFSIDES US FAERS | |
| 47 | Thrombocytopenia | FAERS: 16 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 48 | Accidental overdose | FAERS: 15 | US FAERS | |
| 49 | Application site irritation | FAERS: 15 | SIDER US FAERS | |
| 50 | Ataxia | FAERS: 15 Canada Vigilance: 2 | 7571352 | CTD SIDER Canada Vigilance US FAERS |
| 51 | Arthralgia | FAERS: 14 Canada Vigilance: 2 | Canada Vigilance SIDER US FAERS | |
| 52 | Dehydration | FAERS: 14 | SIDER US FAERS | |
| 53 | Product solubility abnormal | FAERS: 14 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 54 | Respiratory Failure | FAERS: 14 | OFFSIDES US FAERS | |
| 55 | Abdominal discomfort | FAERS: 13 | SIDER US FAERS | |
| 56 | Application site pain | FAERS: 13 Canada Vigilance: 2 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 57 | Lethargy | FAERS: 13 | CTD SIDER US FAERS | |
| 58 | Maternal exposure during pregnancy | FAERS: 13 | US FAERS | |
| 59 | Memory impairment | FAERS: 13 | US FAERS | |
| 60 | No adverse event | FAERS: 13 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 61 | Oliguria | FAERS: 13 | US FAERS | |
| 62 | Product use issue | FAERS: 13 | US FAERS | |
| 63 | Renal tubular necrosis | FAERS: 13 | OFFSIDES US FAERS | |
| 64 | Anxiety | FAERS: 12 Canada Vigilance: 2 | Canada Vigilance OFFSIDES US FAERS | |
| 65 | Disseminated Intravascular Coagulation | FAERS: 12 | OFFSIDES SIDER US FAERS | |
| 66 | Drug level increased | FAERS: 12 | US FAERS | |
| 67 | Dyslalia | FAERS: 12 | OFFSIDES US FAERS | |
| 68 | Dysphonia | FAERS: 12 Canada Vigilance: 2 | Canada Vigilance OFFSIDES US FAERS | |
| 69 | Incorrect dose administered | FAERS: 12 | US FAERS | |
| 70 | Scab | FAERS: 12 | OFFSIDES US FAERS | |
| 71 | Visual Impairment | FAERS: 12 | US FAERS | |
| 72 | Back Pain | FAERS: 11 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 73 | Crystal nephropathy | FAERS: 11 | US FAERS | |
| 74 | Disease recurrence | FAERS: 11 | OFFSIDES US FAERS | |
| 75 | Drug administration error | FAERS: 11 | US FAERS | |
| 76 | Drug toxicity | FAERS: 11 | OFFSIDES US FAERS | |
| 77 | Hypotension | FAERS: 11 | 9865134 | CTD SIDER US FAERS |
| 78 | Incoherent | FAERS: 11 | US FAERS | |
| 79 | Incorrect route of drug administration | FAERS: 11 | US FAERS | |
| 80 | Lip swelling | FAERS: 11 | US FAERS | |
| 81 | Viral mutation identified | FAERS: 11 | US FAERS | |
| 82 | Alanine Aminotransferase Increased | FAERS: 10 | OFFSIDES SIDER US FAERS | |
| 83 | Amnesia | FAERS: 10 | US FAERS | |
| 84 | Aspartate Aminotransferase Increased | FAERS: 10 | SIDER US FAERS | |
| 85 | Blood urea increased | FAERS: 10 | OFFSIDES SIDER US FAERS | |
| 86 | Discomfort | FAERS: 10 | SIDER US FAERS | |
| 87 | Drug dispensing error | FAERS: 10 | US FAERS | |
| 88 | Infection | FAERS: 10 | OFFSIDES US FAERS | |
| 89 | Electroencephalogram abnormal | FAERS: 9 | US FAERS | |
| 90 | Feeling abnormal | FAERS: 9 | SIDER US FAERS | |
| 91 | Palpitations | FAERS: 9 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 92 | Pancreatitis | FAERS: 9 | US FAERS | |
| 93 | Psychiatric symptom | FAERS: 9 | US FAERS | |
| 94 | VIIth nerve paralysis | FAERS: 9 | US FAERS | |
| 95 | Anorexia | FAERS: 8 | OFFSIDES SIDER US FAERS | |
| 96 | Blood sodium decreased | FAERS: 8 | US FAERS | |
| 97 | Bronchospasm | FAERS: 8 | US FAERS | |
| 98 | Chest Pain | FAERS: 8 | SIDER US FAERS | |
| 99 | Diplopia | FAERS: 8 | US FAERS | |
| 100 | Expired drug administered | FAERS: 8 | US FAERS | |
| 101 | Injection site necrosis | FAERS: 8 | US FAERS | |
| 102 | Myalgia | FAERS: 8 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 103 | Product use in unapproved indication | FAERS: 8 | US FAERS | |
| 104 | Rhabdomyolysis | FAERS: 8 | US FAERS | |
| 105 | Swelling | FAERS: 8 | US FAERS | |
| 106 | Therapeutic response unexpected | FAERS: 8 | US FAERS | |
| 107 | Vertigo | FAERS: 8 | SIDER US FAERS | |
| 108 | Angioedema | FAERS: 7 | SIDER US FAERS | |
| 109 | Anuria | FAERS: 7 | OFFSIDES SIDER US FAERS | |
| 110 | Application site erythema | FAERS: 7 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 111 | Blindness | FAERS: 7 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 112 | Cardiac Arrest | FAERS: 7 | US FAERS | |
| 113 | Chromaturia | FAERS: 7 | US FAERS | |
| 114 | Deafness | FAERS: 7 | US FAERS | |
| 115 | Drug effect incomplete | FAERS: 7 | US FAERS | |
| 116 | Genital Herpes | FAERS: 7 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 117 | Infusion Site Extravasation | FAERS: 7 | OFFSIDES US FAERS | |
| 118 | Metabolic acidosis | FAERS: 7 | OFFSIDES US FAERS | |
| 119 | Musculoskeletal stiffness | FAERS: 7 | OFFSIDES US FAERS | |
| 120 | Oropharyngeal pain | FAERS: 7 | OFFSIDES SIDER US FAERS | |
| 121 | Pancytopenia | FAERS: 7 | US FAERS | |
| 122 | Rash erythematous | FAERS: 7 | US FAERS | |
| 123 | Respiratory distress | FAERS: 7 | US FAERS | |
| 124 | Spina Bifida | FAERS: 7 | US FAERS | |
| 125 | Stevens-Johnson Syndrome | FAERS: 7 | 25811541 | CTD OFFSIDES SIDER US FAERS |
| 126 | Urinary Retention | FAERS: 7 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 127 | Wrong technique in product usage process | FAERS: 7 | US FAERS | |
| 128 | Blood creatine phosphokinase increased | FAERS: 6 | US FAERS | |
| 129 | Bradycardia | FAERS: 6 | 9865134 | CTD US FAERS |
| 130 | Bronchopneumonia | FAERS: 6 | US FAERS | |
| 131 | Cerebral atrophy | FAERS: 6 | US FAERS | |
| 132 | Chest discomfort | FAERS: 6 | US FAERS | |
| 133 | Diet refusal | FAERS: 6 | US FAERS | |
| 134 | Dry skin | FAERS: 6 | OFFSIDES US FAERS | |
| 135 | Dysgeusia | FAERS: 6 | SIDER US FAERS | |
| 136 | Expired product administered | FAERS: 6 | US FAERS | |
| 137 | Eye irritation | FAERS: 6 | US FAERS | |
| 138 | General physical health deterioration | FAERS: 6 | OFFSIDES US FAERS | |
| 139 | Graft dysfunction | FAERS: 6 | OFFSIDES US FAERS | |
| 140 | Injection site extravasation | FAERS: 6 | US FAERS | |
| 141 | Nervousness | FAERS: 6 | US FAERS | |
| 142 | Phlebitis | FAERS: 6 | SIDER US FAERS | |
| 143 | Proteinuria | FAERS: 6 Canada Vigilance: 1 | 8442906 | CTD Canada Vigilance US FAERS |
| 144 | Sepsis | FAERS: 6 | US FAERS | |
| 145 | Skin necrosis | FAERS: 6 | US FAERS | |
| 146 | Thirst | FAERS: 6 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 147 | Throat irritation | FAERS: 6 | US FAERS | |
| 148 | Transaminases increased | FAERS: 6 | US FAERS | |
| 149 | Unresponsive to stimuli | FAERS: 6 | OFFSIDES US FAERS | |
| 150 | Visual disturbance | FAERS: 6 | US FAERS | |
| 151 | Abasia | FAERS: 5 | US FAERS | |
| 152 | Accidental exposure | FAERS: 5 | US FAERS | |
| 153 | Ascites | FAERS: 5 | OFFSIDES US FAERS | |
| 154 | Asterixis | FAERS: 5 | US FAERS | |
| 155 | Bradykinesia | FAERS: 5 | US FAERS | |
| 156 | Bradyphrenia | FAERS: 5 | US FAERS | |
| 157 | Corneal lesion | FAERS: 5 | US FAERS | |
| 158 | Dermatitis | FAERS: 5 | SIDER US FAERS | |
| 159 | Drug prescribing error | FAERS: 5 | US FAERS | |
| 160 | Epistaxis | FAERS: 5 | OFFSIDES US FAERS | |
| 161 | Erythema Multiforme | FAERS: 5 | SIDER US FAERS | |
| 162 | Glaucoma | FAERS: 5 | US FAERS | |
| 163 | Hepatotoxicity | FAERS: 5 | OFFSIDES US FAERS | |
| 164 | Mouth swelling | FAERS: 5 | US FAERS | |
| 165 | Neuralgia | FAERS: 5 Canada Vigilance: 1 | 16682531 | CTD OFFSIDES Canada Vigilance US FAERS |
| 166 | Neutropenia | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 167 | Nystagmus | FAERS: 5 | US FAERS | |
| 168 | Paresis | FAERS: 5 | US FAERS | |
| 169 | Peripheral swelling | FAERS: 5 | US FAERS | |
| 170 | Photophobia | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 171 | Syncope | FAERS: 5 | US FAERS | |
| 172 | Vasculitis | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 173 | Wheezing | FAERS: 5 | US FAERS | |
| 174 | White blood cell count decreased | FAERS: 5 | US FAERS | |
| 175 | jaundice | FAERS: 5 | SIDER US FAERS | |
| 176 | Accidental exposure to product | FAERS: 4 | US FAERS | |
| 177 | Antiviral drug level above therapeutic | FAERS: 4 | US FAERS | |
| 178 | Application site reaction | FAERS: 4 | SIDER US FAERS | |
| 179 | Cerebral Infarction | FAERS: 4 | US FAERS | |
| 180 | Cheilitis | FAERS: 4 | US FAERS | |
| 181 | Choking | FAERS: 4 | US FAERS | |
| 182 | Corneal Opacity | FAERS: 4 | US FAERS | |
| 183 | Cytomegalovirus syndrome | FAERS: 4 | US FAERS | |
| 184 | Disease Progression | FAERS: 4 | OFFSIDES US FAERS | |
| 185 | Drug ineffective for unapproved indication | FAERS: 4 | US FAERS | |
| 186 | Emotional disorder | FAERS: 4 | US FAERS | |
| 187 | Emotional distress | FAERS: 4 | OFFSIDES US FAERS | |
| 188 | Flank Pain | FAERS: 4 | US FAERS | |
| 189 | Gout | FAERS: 4 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 190 | Hallucinations, mixed | FAERS: 4 | SIDER US FAERS | |
| 191 | Hepatitis | FAERS: 4 | OFFSIDES SIDER US FAERS | |
| 192 | Immune thrombocytopenic purpura | FAERS: 4 | US FAERS | |
| 193 | Incorrect drug administration duration | FAERS: 4 | US FAERS | |
| 194 | Incorrect drug dosage form administered | FAERS: 4 | US FAERS | |
| 195 | Injection site vesicles | FAERS: 4 | US FAERS | |
| 196 | Keratitis | FAERS: 4 | US FAERS | |
| 197 | Leukopenia | FAERS: 4 | 2741918 | CTD SIDER US FAERS |
| 198 | Macrocytosis | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance OFFSIDES US FAERS | |
| 199 | Monoplegia | FAERS: 4 | US FAERS | |
| 200 | Nuchal Rigidity | FAERS: 4 | US FAERS | |
| 201 | Paranoia | FAERS: 4 | OFFSIDES US FAERS | |
| 202 | Pneumonia | FAERS: 4 | US FAERS | |
| 203 | Posterior reversible encephalopathy syndrome | FAERS: 4 | US FAERS | |
| 204 | Prescribed underdose | FAERS: 4 | US FAERS | |
| 205 | Product coating issue | FAERS: 4 | US FAERS | |
| 206 | Retinitis | FAERS: 4 | US FAERS | |
| 207 | Rhinitis | FAERS: 4 | US FAERS | |
| 208 | Sinus bradycardia | FAERS: 4 | US FAERS | |
| 209 | Skin irritation | FAERS: 4 | US FAERS | |
| 210 | Soliloquy | FAERS: 4 | US FAERS | |
| 211 | Status Epilepticus | FAERS: 4 | US FAERS | |
| 212 | Stomatitis | FAERS: 4 | US FAERS | |
| 213 | Tachycardia | FAERS: 4 | SIDER US FAERS | |
| 214 | Therapy cessation | FAERS: 4 | US FAERS | |
| 215 | Unevaluable event | FAERS: 4 | OFFSIDES US FAERS | |
| 216 | Urinary tract infection | FAERS: 4 | US FAERS | |
| 217 | Viral vasculitis | FAERS: 4 | US FAERS | |
| 218 | Weight decreased | FAERS: 4 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 219 | Wrong technique in drug usage process | FAERS: 4 | US FAERS | |
| 220 | Agranulocytosis | FAERS: 3 | US FAERS | |
| 221 | Anaphylactic shock | FAERS: 3 | SIDER US FAERS | |
| 222 | Anaphylactoid Reaction | FAERS: 3 | US FAERS | |
| 223 | Blister rupture | FAERS: 3 | US FAERS | |
| 224 | Blood creatine increased | FAERS: 3 | US FAERS | |
| 225 | Blood urine present | FAERS: 3 | US FAERS | |
| 226 | Cerebral ventricle dilatation | FAERS: 3 | US FAERS | |
| 227 | Constipation | FAERS: 3 | SIDER US FAERS | |
| 228 | Corneal epithelium disorder | FAERS: 3 | US FAERS | |
| 229 | Crying | FAERS: 3 | US FAERS | |
| 230 | Delusional disorder, persecutory type | FAERS: 3 | US FAERS | |
| 231 | Dementia | FAERS: 3 | US FAERS | |
| 232 | Depressed mood | FAERS: 3 | US FAERS | |
| 233 | Disability | FAERS: 3 | US FAERS | |
| 234 | Drug administered to patient of inappropriate age | FAERS: 3 | US FAERS | |
| 235 | Dysuria | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance OFFSIDES US FAERS | |
| 236 | Elevated mood | FAERS: 3 | US FAERS | |
| 237 | Erysipelas | FAERS: 3 | US FAERS | |
| 238 | Exposure during breast feeding | FAERS: 3 | US FAERS | |
| 239 | Eye Infection | FAERS: 3 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 240 | Gait inability | FAERS: 3 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 241 | Gastrointestinal perforation | FAERS: 3 | US FAERS | |
| 242 | Genital burning sensation | FAERS: 3 | US FAERS | |
| 243 | Glasgow coma scale abnormal | FAERS: 3 | US FAERS | |
| 244 | Hemiparesis | FAERS: 3 | US FAERS | |
| 245 | Hepatitis B | FAERS: 3 | 6841304 | CTD OFFSIDES US FAERS |
| 246 | Hypersomnia | FAERS: 3 | US FAERS | |
| 247 | Hypophagia | FAERS: 3 | OFFSIDES US FAERS | |
| 248 | Incontinence | FAERS: 3 | US FAERS | |
| 249 | Intestinal Perforation | FAERS: 3 | US FAERS | |
| 250 | Leukocytosis | FAERS: 3 | SIDER US FAERS | |
| 251 | Lip erosion | FAERS: 3 | OFFSIDES US FAERS | |
| 252 | Live Birth | FAERS: 3 | US FAERS | |
| 253 | Meningitis herpes | FAERS: 3 | US FAERS | |
| 254 | Mydriasis | FAERS: 3 | US FAERS | |
| 255 | Nasal discomfort | FAERS: 3 | US FAERS | |
| 256 | Nasopharyngitis | FAERS: 3 | SIDER US FAERS | |
| 257 | Necrosis | FAERS: 3 | 15969948 21319040 | CTD SIDER US FAERS |
| 258 | Nerve injury | FAERS: 3 | US FAERS | |
| 259 | Obstructive nephropathy | FAERS: 3 | US FAERS | |
| 260 | Oral pain | FAERS: 3 | US FAERS | |
| 261 | Poisoning | FAERS: 3 | US FAERS | |
| 262 | Pregnancy | FAERS: 3 | US FAERS | |
| 263 | Product container issue | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 264 | Product physical issue | FAERS: 3 | US FAERS | |
| 265 | Product taste abnormal | FAERS: 3 | US FAERS | |
| 266 | Product use complaint | FAERS: 3 | US FAERS | |
| 267 | Prothrombin time abnormal | FAERS: 3 | US FAERS | |
| 268 | Purulent discharge | FAERS: 3 | US FAERS | |
| 269 | Renal pain | FAERS: 3 | SIDER US FAERS | |
| 270 | Respiratory arrest | FAERS: 3 | US FAERS | |
| 271 | Skin Erosion | FAERS: 3 | OFFSIDES US FAERS | |
| 272 | Therapeutic product cross-reactivity | FAERS: 3 | US FAERS | |
| 273 | Thrombophlebitis | FAERS: 3 | 3598154 | CTD US FAERS |
| 274 | Virus culture positive | FAERS: 3 | US FAERS | |
| 275 | Accidental exposure to product by child | FAERS: 2 | US FAERS | |
| 276 | Adverse event | FAERS: 2 | US FAERS | |
| 277 | Alanine aminotransferase abnormal | FAERS: 2 | US FAERS | |
| 278 | Application site pruritus | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 279 | Arthritis | FAERS: 2 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 280 | Aspartate aminotransferase abnormal | FAERS: 2 | US FAERS | |
| 281 | Athetosis | FAERS: 2 | US FAERS | |
| 282 | Beta 2 microglobulin urine increased | FAERS: 2 | US FAERS | |
| 283 | Blood glucose increased | FAERS: 2 | US FAERS | |
| 284 | Blood lactate dehydrogenase increased | FAERS: 2 | OFFSIDES US FAERS | |
| 285 | Blood potassium decreased | FAERS: 2 | OFFSIDES US FAERS | |
| 286 | Bone marrow toxicity | FAERS: 2 | OFFSIDES US FAERS | |
| 287 | Bowel movement irregularity | FAERS: 2 | US FAERS | |
| 288 | Cellulitis | FAERS: 2 | US FAERS | |
| 289 | Cerebral disorder | FAERS: 2 | US FAERS | |
| 290 | Cerebrovascular accident | FAERS: 2 | US FAERS | |
| 291 | Cholestasis | FAERS: 2 | US FAERS | |
| 292 | Choreoathetosis | FAERS: 2 | US FAERS | |
| 293 | Cold sweat | FAERS: 2 | US FAERS | |
| 294 | Complications of transplant surgery | FAERS: 2 | US FAERS | |
| 295 | Corneal Scar | FAERS: 2 | US FAERS | |
| 296 | Corneal dystrophy | FAERS: 2 | US FAERS | |
| 297 | Crystalluria | FAERS: 2 | US FAERS | |
| 298 | Cystitis | FAERS: 2 | 2837588 | CTD US FAERS |
| 299 | Drug abuse | FAERS: 2 | US FAERS | |
| 300 | Drug dose omission | FAERS: 2 | US FAERS | |
| 301 | Drug level decreased | FAERS: 2 | US FAERS | |
| 302 | Dysphasia | FAERS: 2 | US FAERS | |
| 303 | Ear discomfort | FAERS: 2 | US FAERS | |
| 304 | Eczema | FAERS: 2 | SIDER US FAERS | |
| 305 | Electrocardiogram abnormal | FAERS: 2 | US FAERS | |
| 306 | Encephalomalacia | FAERS: 2 | US FAERS | |
| 307 | Extra dose administered | FAERS: 2 | US FAERS | |
| 308 | Facial paralysis | FAERS: 2 | US FAERS | |
| 309 | Failure to Thrive | FAERS: 2 | OFFSIDES US FAERS | |
| 310 | Flatulence | FAERS: 2 | SIDER US FAERS | |
| 311 | Flushing | FAERS: 2 | US FAERS | |
| 312 | Gamma-Glutamyltransferase Increased | FAERS: 2 | US FAERS | |
| 313 | Gastric ulcer | FAERS: 2 | US FAERS | |
| 314 | General physical condition abnormal | FAERS: 2 | US FAERS | |
| 315 | Guillain-Barre Syndrome | FAERS: 2 | US FAERS | |
| 316 | Hepatic necrosis | FAERS: 2 | OFFSIDES US FAERS | |
| 317 | Hepatitis B surface antibody positive | FAERS: 2 | US FAERS | |
| 318 | Hepatitis B surface antigen positive | FAERS: 2 | US FAERS | |
| 319 | Herpes pharyngitis | FAERS: 2 | US FAERS | |
| 320 | Herpes simplex pneumonia | FAERS: 2 | US FAERS | |
| 321 | Hyperkinesia | FAERS: 2 | US FAERS | |
| 322 | Hypospadias | FAERS: 2 | US FAERS | |
| 323 | Impaired work ability | FAERS: 2 | US FAERS | |
| 324 | Impetigo | FAERS: 2 | US FAERS | |
| 325 | Inappropriate schedule of drug administration | FAERS: 2 | US FAERS | |
| 326 | Infusion site necrosis | FAERS: 2 | US FAERS | |
| 327 | Injection site thrombosis | FAERS: 2 | US FAERS | |
| 328 | Iridocyclitis | FAERS: 2 | US FAERS | |
| 329 | Malignant Hypertension | FAERS: 2 | US FAERS | |
| 330 | Mechanical ventilation | FAERS: 2 | US FAERS | |
| 331 | Monoparesis | FAERS: 2 | US FAERS | |
| 332 | Multiple Sclerosis | FAERS: 2 | US FAERS | |
| 333 | Muscle Rigidity | FAERS: 2 | US FAERS | |
| 334 | Neonatal disorder | FAERS: 2 | US FAERS | |
| 335 | Neonatal pneumonia | FAERS: 2 | US FAERS | |
| 336 | Neonatal respiratory failure | FAERS: 2 | US FAERS | |
| 337 | Neurological decompensation | FAERS: 2 | OFFSIDES US FAERS | |
| 338 | Neurosyphilis | FAERS: 2 | US FAERS | |
| 339 | Neutropenic sepsis | FAERS: 2 | OFFSIDES US FAERS | |
| 340 | Neutrophil count decreased | FAERS: 2 | US FAERS | |
| 341 | Nonspecific reaction | FAERS: 2 | US FAERS | |
| 342 | Ophthalmoplegia | FAERS: 2 | US FAERS | |
| 343 | Optic Neuritis | FAERS: 2 | US FAERS | |
| 344 | Personality Change | FAERS: 2 | US FAERS | |
| 345 | Pharyngolaryngeal Pain | FAERS: 2 | US FAERS | |
| 346 | Pneumatosis intestinalis | FAERS: 2 | US FAERS | |
| 347 | Pneumothorax | FAERS: 2 | OFFSIDES US FAERS | |
| 348 | Presyncope | FAERS: 2 | US FAERS | |
| 349 | Product label issue | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 350 | Product physical consistency issue | FAERS: 2 | US FAERS | |
| 351 | Product preparation error | FAERS: 2 | US FAERS | |
| 352 | Prothrombin level decreased | FAERS: 2 | US FAERS | |
| 353 | Punctate keratitis | FAERS: 2 | SIDER US FAERS | |
| 354 | Pyelonephritis | FAERS: 2 | US FAERS | |
| 355 | Quadriplegia | FAERS: 2 | US FAERS | |
| 356 | Refusal of treatment by relative | FAERS: 2 | US FAERS | |
| 357 | Renal failure neonatal | FAERS: 2 | US FAERS | |
| 358 | Renal tubular disorder | FAERS: 2 | US FAERS | |
| 359 | Retinal Detachment | FAERS: 2 | US FAERS | |
| 360 | Septic Shock | FAERS: 2 | OFFSIDES US FAERS | |
| 361 | Serum Sickness | FAERS: 2 | US FAERS | |
| 362 | Shock | FAERS: 2 | US FAERS | |
| 363 | Sinus Tachycardia | FAERS: 2 | US FAERS | |
| 364 | Sinusitis | FAERS: 2 | OFFSIDES US FAERS | |
| 365 | Skin reaction | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 366 | Sneezing | FAERS: 2 | US FAERS | |
| 367 | Soft tissue necrosis | FAERS: 2 | US FAERS | |
| 368 | Staring | FAERS: 2 | US FAERS | |
| 369 | Therapeutic response unexpected with drug substitution | FAERS: 2 | US FAERS | |
| 370 | Thrombosis | FAERS: 2 | US FAERS | |
| 371 | Tinnitus | FAERS: 2 | OFFSIDES US FAERS | |
| 372 | Toxic Epidermal Necrolysis | FAERS: 2 | SIDER US FAERS | |
| 373 | Venous Thrombosis | FAERS: 2 | US FAERS | |
| 374 | 2',5'-oligoadenylate synthetase test decreased | FAERS: 1 | US FAERS | |
| 375 | Abdominal rigidity | FAERS: 1 | US FAERS | |
| 376 | Acanthamoeba Infection | FAERS: 1 | US FAERS | |
| 377 | Acidosis | FAERS: 1 | US FAERS | |
| 378 | Administration site extravasation | FAERS: 1 | US FAERS | |
| 379 | Agnosia | FAERS: 1 | US FAERS | |
| 380 | Albuminuria | FAERS: 1 | US FAERS | |
| 381 | Anal Ulcer | FAERS: 1 | US FAERS | |
| 382 | Anger | FAERS: 1 | US FAERS | |
| 383 | Angina Pectoris | FAERS: 1 | US FAERS | |
| 384 | Anhedonia | FAERS: 1 | OFFSIDES US FAERS | |
| 385 | Anti-thyroid antibody positive | FAERS: 1 | US FAERS | |
| 386 | Apathy | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 387 | Aphonia | FAERS: 1 | US FAERS | |
| 388 | Application site dryness | FAERS: 1 | US FAERS | |
| 389 | Application site erosion | FAERS: 1 | US FAERS | |
| 390 | Application site exfoliation | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 391 | Application site inflammation | FAERS: 1 | US FAERS | |
| 392 | Application site laceration | FAERS: 1 | US FAERS | |
| 393 | Application site scar | FAERS: 1 | US FAERS | |
| 394 | Application site swelling | FAERS: 1 | US FAERS | |
| 395 | Aspergillosis | FAERS: 1 | US FAERS | |
| 396 | Asthenopia | FAERS: 1 | US FAERS | |
| 397 | Atrial Fibrillation | FAERS: 1 | US FAERS | |
| 398 | Auricular swelling | FAERS: 1 | US FAERS | |
| 399 | Axonal neuropathy | FAERS: 1 | US FAERS | |
| 400 | Biopsy skin abnormal | FAERS: 1 | US FAERS | |
| 401 | Bladder pain | FAERS: 1 | US FAERS | |
| 402 | Blood alkaline phosphatase increased | FAERS: 1 | OFFSIDES SIDER US FAERS | |
| 403 | Blood creatinine abnormal | FAERS: 1 | US FAERS | |
| 404 | Blood fibrinogen decreased | FAERS: 1 | US FAERS | |
| 405 | Bone pain | FAERS: 1 | OFFSIDES US FAERS | |
| 406 | Brucellosis | FAERS: 1 | US FAERS | |
| 407 | Bullous impetigo | FAERS: 1 | US FAERS | |
| 408 | CD4 Lymphocytes Decreased | FAERS: 1 | US FAERS | |
| 409 | Candida test positive | FAERS: 1 | US FAERS | |
| 410 | Candidiasis | FAERS: 1 | US FAERS | |
| 411 | Catheter site erythema | FAERS: 1 | US FAERS | |
| 412 | Catheter site necrosis | FAERS: 1 | US FAERS | |
| 413 | Central nervous system lesion | FAERS: 1 | US FAERS | |
| 414 | Chills | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 415 | Circumstance or information capable of leading to medication error | FAERS: 1 | US FAERS | |
| 416 | Clonus | FAERS: 1 | US FAERS | |
| 417 | Coma scale abnormal | FAERS: 1 | US FAERS | |
| 418 | Complications of maternal exposure to therapeutic drugs | FAERS: 1 | US FAERS | |
| 419 | Congenital cystic kidney disease | FAERS: 1 | US FAERS | |
| 420 | Conjunctivitis | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance SIDER US FAERS | |
| 421 | Consciousness fluctuating | FAERS: 1 | US FAERS | |
| 422 | Corneal Perforation | FAERS: 1 | US FAERS | |
| 423 | Cotard's syndrome | FAERS: 1 | US FAERS | |
| 424 | Creatinine renal clearance decreased | FAERS: 1 | US FAERS | |
| 425 | Crystal urine present | FAERS: 1 | US FAERS | |
| 426 | Culture urine positive | FAERS: 1 | US FAERS | |
| 427 | Cyanopsia | FAERS: 1 | US FAERS | |
| 428 | Cytomegalovirus chorioretinitis | FAERS: 1 | US FAERS | |
| 429 | Cytomegalovirus gastroenteritis | FAERS: 1 | US FAERS | |
| 430 | Cytomegalovirus hepatitis | FAERS: 1 | US FAERS | |
| 431 | Decreased immune responsiveness | FAERS: 1 | US FAERS | |
| 432 | Device Failure | FAERS: 1 | US FAERS | |
| 433 | Device ineffective | FAERS: 1 | US FAERS | |
| 434 | Device related infection | FAERS: 1 | US FAERS | |
| 435 | Diabetic Ketoacidosis | FAERS: 1 | US FAERS | |
| 436 | Dialysis device insertion | FAERS: 1 | US FAERS | |
| 437 | Dreamy state | FAERS: 1 | US FAERS | |
| 438 | Drug administered at inappropriate site | FAERS: 1 | US FAERS | |
| 439 | Drug dose titration not performed | FAERS: 1 | US FAERS | |
| 440 | Drug effective for unapproved indication | FAERS: 1 | US FAERS | |
| 441 | Drug exposure via breast milk | FAERS: 1 | US FAERS | |
| 442 | Drug level above therapeutic | FAERS: 1 | US FAERS | |
| 443 | Drug level below therapeutic | FAERS: 1 | US FAERS | |
| 444 | Drug monitoring procedure not performed | FAERS: 1 | US FAERS | |
| 445 | Dysentery | FAERS: 1 | US FAERS | |
| 446 | Dyspepsia | FAERS: 1 | OFFSIDES SIDER US FAERS | |
| 447 | Ecchymosis | FAERS: 1 | US FAERS | |
| 448 | Enterocolitis | FAERS: 1 | US FAERS | |
| 449 | Eschar | FAERS: 1 | US FAERS | |
| 450 | Eye inflammation | FAERS: 1 | US FAERS | |
| 451 | Eyeball avulsion | FAERS: 1 | US FAERS | |
| 452 | Eyelid margin crusting | FAERS: 1 | US FAERS | |
| 453 | Eyelid pain | FAERS: 1 | US FAERS | |
| 454 | Fasciitis | FAERS: 1 | US FAERS | |
| 455 | Febrile Neutropenia | FAERS: 1 | OFFSIDES US FAERS | |
| 456 | Feeling Cold | FAERS: 1 | US FAERS | |
| 457 | Feeling jittery | FAERS: 1 | US FAERS | |
| 458 | Feeling of body temperature change | FAERS: 1 | US FAERS | |
| 459 | Fibrosis | FAERS: 1 | US FAERS | |
| 460 | Fluid overload | FAERS: 1 | OFFSIDES US FAERS | |
| 461 | Gastric mucosa erythema | FAERS: 1 | US FAERS | |
| 462 | Gastritis | FAERS: 1 | US FAERS | |
| 463 | Gastrointestinal Pain | FAERS: 1 | SIDER US FAERS | |
| 464 | Gastrointestinal mucosal disorder | FAERS: 1 | US FAERS | |
| 465 | Gaze palsy | FAERS: 1 | US FAERS | |
| 466 | Gene Mutation | FAERS: 1 | US FAERS | |
| 467 | General symptom | FAERS: 1 | US FAERS | |
| 468 | Genital discomfort | FAERS: 1 | US FAERS | |
| 469 | Genital rash | FAERS: 1 | US FAERS | |
| 470 | Glossitis | FAERS: 1 | US FAERS | |
| 471 | Gluten sensitivity | FAERS: 1 | US FAERS | |
| 472 | Glycosuria | FAERS: 1 | 8442906 | CTD US FAERS |
| 473 | Graft versus host disease in lung | FAERS: 1 | US FAERS | |
| 474 | HELLP Syndrome | FAERS: 1 | US FAERS | |
| 475 | Hemiplegia | FAERS: 1 | US FAERS | |
| 476 | Hepatosplenomegaly | FAERS: 1 | OFFSIDES US FAERS | |
| 477 | Herpes Zoster Oticus | FAERS: 1 | 19278487 | CTD US FAERS |
| 478 | Herpes simplex DNA test positive | FAERS: 1 | US FAERS | |
| 479 | Herpes simplex serology positive | FAERS: 1 | US FAERS | |
| 480 | Herpes zoster meningomyelitis | FAERS: 1 | US FAERS | |
| 481 | Histiocytosis haematophagic | FAERS: 1 | OFFSIDES US FAERS | |
| 482 | Hydrocephalus | FAERS: 1 | US FAERS | |
| 483 | Hypercreatininaemia | FAERS: 1 | US FAERS | |
| 484 | Hyperreflexia | FAERS: 1 | OFFSIDES US FAERS | |
| 485 | Hypertensive crisis | FAERS: 1 | US FAERS | |
| 486 | Hyperventilation | FAERS: 1 | US FAERS | |
| 487 | Hypomania | FAERS: 1 | US FAERS | |
| 488 | Hyporesponsive to stimuli | FAERS: 1 | US FAERS | |
| 489 | Immobile | FAERS: 1 | US FAERS | |
| 490 | Immune reconstitution syndrome | FAERS: 1 | US FAERS | |
| 491 | Impatience | FAERS: 1 | US FAERS | |
| 492 | Inappropriate schedule of product administration | FAERS: 1 | US FAERS | |
| 493 | Incorrect product administration duration | FAERS: 1 | US FAERS | |
| 494 | Increased tendency to bruise | FAERS: 1 | US FAERS | |
| 495 | Infection reactivation | FAERS: 1 | US FAERS | |
| 496 | Inflammation | FAERS: 1 | SIDER US FAERS | |
| 497 | Influenza | FAERS: 1 | US FAERS | |
| 498 | Infusion site erosion | FAERS: 1 | US FAERS | |
| 499 | Infusion site reaction | FAERS: 1 | US FAERS | |
| 500 | Injection site inflammation | FAERS: 1 | US FAERS | |
| 501 | Injection site pain | FAERS: 1 | US FAERS | |
| 502 | Injection site phlebitis | FAERS: 1 | SIDER US FAERS | |
| 503 | Instillation site vesicles | FAERS: 1 | US FAERS | |
| 504 | Intellectual Disability | FAERS: 1 | US FAERS | |
| 505 | Intentional drug misuse | FAERS: 1 | US FAERS | |
| 506 | Intentional product use issue | FAERS: 1 | US FAERS | |
| 507 | Intercepted drug dispensing error | FAERS: 1 | US FAERS | |
| 508 | Intercepted medication error | FAERS: 1 | US FAERS | |
| 509 | Irregular breathing | FAERS: 1 | US FAERS | |
| 510 | Irritable Bowel Syndrome | FAERS: 1 | US FAERS | |
| 511 | JC virus infection | FAERS: 1 | US FAERS | |
| 512 | Joint stiffness | FAERS: 1 | US FAERS | |
| 513 | Joint swelling | FAERS: 1 | US FAERS | |
| 514 | Leukocytoclastic vasculitis | FAERS: 1 | SIDER US FAERS | |
| 515 | Leukostasis | FAERS: 1 | US FAERS | |
| 516 | Locked-In Syndrome | FAERS: 1 | US FAERS | |
| 517 | Loss of personal independence in daily activities | FAERS: 1 | US FAERS | |
| 518 | Lower respiratory tract infection | FAERS: 1 | US FAERS | |
| 519 | Lumbar puncture abnormal | FAERS: 1 | US FAERS | |
| 520 | Lung consolidation | FAERS: 1 | OFFSIDES US FAERS | |
| 521 | Lymphadenopathy | FAERS: 1 | SIDER US FAERS | |
| 522 | Lymphocyte count decreased | FAERS: 1 | US FAERS | |
| 523 | Lymphocyte percentage increased | FAERS: 1 | US FAERS | |
| 524 | Lymphocytic infiltration | FAERS: 1 | US FAERS | |
| 525 | Lymphopenia | FAERS: 1 | US FAERS | |
| 526 | MYELODYSPLASTIC SYNDROME | FAERS: 1 | US FAERS | |
| 527 | Measles | FAERS: 1 | US FAERS | |
| 528 | Medication crystals in urine present | FAERS: 1 | US FAERS | |
| 529 | Medication residue present | FAERS: 1 | US FAERS | |
| 530 | Meningitis | FAERS: 1 | US FAERS | |
| 531 | Mental impairment | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance OFFSIDES US FAERS | |
| 532 | Metamorphopsia | FAERS: 1 | US FAERS | |
| 533 | Moaning | FAERS: 1 | US FAERS | |
| 534 | Mood swings | FAERS: 1 | US FAERS | |
| 535 | Multi-organ disorder | FAERS: 1 | US FAERS | |
| 536 | Multiple allergies | FAERS: 1 | US FAERS | |
| 537 | Muscle Spasticity | FAERS: 1 | US FAERS | |
| 538 | Musculoskeletal chest pain | FAERS: 1 | OFFSIDES US FAERS | |
| 539 | Musculoskeletal discomfort | FAERS: 1 | SIDER US FAERS | |
| 540 | Myocardial necrosis marker increased | FAERS: 1 | US FAERS | |
| 541 | Myopathy | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 542 | Myopia | FAERS: 1 | US FAERS | |
| 543 | Myositis | FAERS: 1 | US FAERS | |
| 544 | Neonatal hypotension | FAERS: 1 | US FAERS | |
| 545 | Neonatal infection | FAERS: 1 | US FAERS | |
| 546 | Neonatal mucocutaneous herpes simplex | FAERS: 1 | US FAERS | |
| 547 | Nephritic syndrome | FAERS: 1 | US FAERS | |
| 548 | Nephrolithiasis | FAERS: 1 | OFFSIDES US FAERS | |
| 549 | Nephrosclerosis | FAERS: 1 | US FAERS | |
| 550 | Neutrophil percentage decreased | FAERS: 1 | US FAERS | |
| 551 | Oculomucocutaneous syndrome | FAERS: 1 | US FAERS | |
| 552 | Oral candidiasis | FAERS: 1 | US FAERS | |
| 553 | Oropharyngeal discomfort | FAERS: 1 | SIDER US FAERS | |
| 554 | Orthostatic intolerance | FAERS: 1 | US FAERS | |
| 555 | Osteonecrosis of Jaw | FAERS: 1 | US FAERS | |
| 556 | Oxygen saturation abnormal | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 557 | PO2 decreased | FAERS: 1 | US FAERS | |
| 558 | Pain of skin | FAERS: 1 | OFFSIDES US FAERS | |
| 559 | Pallor | FAERS: 1 | OFFSIDES US FAERS | |
| 560 | Penile erythema | FAERS: 1 | US FAERS | |
| 561 | Pericardial effusion | FAERS: 1 | OFFSIDES US FAERS | |
| 562 | Periostosis | FAERS: 1 | US FAERS | |
| 563 | Peritoneal Dialysis | FAERS: 1 | US FAERS | |
| 564 | Petechiae | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 565 | Pleocytosis | FAERS: 1 | US FAERS | |
| 566 | Pneumonia herpes viral | FAERS: 1 | US FAERS | |
| 567 | Polyhydramnios | FAERS: 1 | US FAERS | |
| 568 | Polymyositis | FAERS: 1 | US FAERS | |
| 569 | Polyuria | FAERS: 1 | 14675048 | CTD US FAERS |
| 570 | Poriomania | FAERS: 1 | US FAERS | |
| 571 | Post procedural complication | FAERS: 1 | OFFSIDES US FAERS | |
| 572 | Prescribed overdose | FAERS: 1 | US FAERS | |
| 573 | Procedural complication | FAERS: 1 | US FAERS | |
| 574 | Product adhesion issue | FAERS: 1 | US FAERS | |
| 575 | Product commingling | FAERS: 1 | US FAERS | |
| 576 | Product contamination | FAERS: 1 | US FAERS | |
| 577 | Product contamination physical | FAERS: 1 | US FAERS | |
| 578 | Product difficult to swallow | FAERS: 1 | US FAERS | |
| 579 | Product dispensing error | FAERS: 1 | US FAERS | |
| 580 | Product formulation issue | FAERS: 1 | US FAERS | |
| 581 | Product packaging confusion | FAERS: 1 | US FAERS | |
| 582 | Product size issue | FAERS: 1 | US FAERS | |
| 583 | Product storage error | FAERS: 1 | US FAERS | |
| 584 | Product substitution | FAERS: 1 | US FAERS | |
| 585 | Product used for unknown indication | FAERS: 1 | US FAERS | |
| 586 | Prostatic pain | FAERS: 1 | US FAERS | |
| 587 | Protein urine present | FAERS: 1 | US FAERS | |
| 588 | Psychotic symptom | FAERS: 1 | US FAERS | |
| 589 | Pulmonary Embolism | FAERS: 1 | US FAERS | |
| 590 | Pulmonary Fibrosis | FAERS: 1 | US FAERS | |
| 591 | Purpura | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 592 | Purulence | FAERS: 1 | US FAERS | |
| 593 | Radiculopathy | FAERS: 1 | US FAERS | |
| 594 | Reaction to excipient | FAERS: 1 | US FAERS | |
| 595 | Renal Colic | FAERS: 1 | US FAERS | |
| 596 | Respiratory Depression | FAERS: 1 | US FAERS | |
| 597 | Restless Legs Syndrome | FAERS: 1 | US FAERS | |
| 598 | Retinal infiltrates | FAERS: 1 | US FAERS | |
| 599 | Retinal scar | FAERS: 1 | US FAERS | |
| 600 | Retrograde amnesia | FAERS: 1 | US FAERS | |
| 601 | Rhegmatogenous retinal detachment | FAERS: 1 | US FAERS | |
| 602 | Schizophrenia | FAERS: 1 | US FAERS | |
| 603 | Scleroderma | FAERS: 1 | OFFSIDES US FAERS | |
| 604 | Sensation of blood flow | FAERS: 1 | US FAERS | |
| 605 | Sensory level abnormal | FAERS: 1 | US FAERS | |
| 606 | Skeleton dysplasia | FAERS: 1 | US FAERS | |
| 607 | Skin laceration | FAERS: 1 | US FAERS | |
| 608 | Specific gravity urine decreased | FAERS: 1 | US FAERS | |
| 609 | Spinal column stenosis | FAERS: 1 | US FAERS | |
| 610 | Splenomegaly | FAERS: 1 | US FAERS | |
| 611 | Squamous cell carcinoma | FAERS: 1 | US FAERS | |
| 612 | Sterile pyuria | FAERS: 1 | US FAERS | |
| 613 | Stillbirth | FAERS: 1 | US FAERS | |
| 614 | Stress | FAERS: 1 | US FAERS | |
| 615 | Stupor | FAERS: 1 | 2396095 7973922 12799156 | CTD SIDER US FAERS |
| 616 | Sunburn | FAERS: 1 | US FAERS | |
| 617 | Synovial fluid white blood cells positive | FAERS: 1 | US FAERS | |
| 618 | Syphilis | FAERS: 1 | US FAERS | |
| 619 | Systemic mycosis | FAERS: 1 | US FAERS | |
| 620 | Tension | FAERS: 1 | US FAERS | |
| 621 | Therapeutic product effect incomplete | FAERS: 1 | US FAERS | |
| 622 | Therapy non-responder | FAERS: 1 | US FAERS | |
| 623 | Thermal burn | FAERS: 1 | US FAERS | |
| 624 | Thrombocytopenic purpura | FAERS: 1 | SIDER US FAERS | |
| 625 | Thrombocytosis | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance SIDER US FAERS | |
| 626 | Tongue eruption | FAERS: 1 | US FAERS | |
| 627 | Tooth Loss | FAERS: 1 | US FAERS | |
| 628 | Traumatic lumbar puncture | FAERS: 1 | US FAERS | |
| 629 | Urine leukocyte esterase positive | FAERS: 1 | US FAERS | |
| 630 | Urine output increased | FAERS: 1 | US FAERS | |
| 631 | Vaginal Discharge | FAERS: 1 | US FAERS | |
| 632 | Varicella Zoster Virus Infection | FAERS: 1 | US FAERS | |
| 633 | Vascular access site occlusion | FAERS: 1 | US FAERS | |
| 634 | Vascular encephalopathy | FAERS: 1 | US FAERS | |
| 635 | Venous thrombosis limb | FAERS: 1 | OFFSIDES US FAERS | |
| 636 | Ventricular Fibrillation | FAERS: 1 | US FAERS | |
| 637 | Vulvar erosion | FAERS: 1 | US FAERS | |
| 638 | Vulvovaginal burning sensation | FAERS: 1 | US FAERS | |
| 639 | Wheelchair user | FAERS: 1 | US FAERS | |
| 640 | Xanthopsia | FAERS: 1 | US FAERS | |
| 641 | skin abrasion | FAERS: 1 | US FAERS | |
| 642 | AIDS-Related Opportunistic Infections | 9707315 | CTD | |
| 643 | Abnormal vision | OFFSIDES | ||
| 644 | Abscess | OFFSIDES | ||
| 645 | Accelerated hair loss | SIDER | ||
| 646 | Ache | SIDER | ||
| 647 | Acid reflux | OFFSIDES | ||
| 648 | Acquired Immunodeficiency Syndrome | 2964805 | CTD | |
| 649 | Actinic keratosis | OFFSIDES | ||
| 650 | Actinomycosis | OFFSIDES | ||
| 651 | Activities of daily living impaired | OFFSIDES | ||
| 652 | Acute graft versus host disease in intestine | OFFSIDES | ||
| 653 | Acute graft versus host disease in liver | OFFSIDES | ||
| 654 | Acute psychosis | OFFSIDES | ||
| 655 | Acute respiratory failure | OFFSIDES | ||
| 656 | Acute sinusitis | OFFSIDES | ||
| 657 | Acute vestibular syndrome | OFFSIDES | ||
| 658 | Adenocarcinoma | OFFSIDES | ||
| 659 | Adenoma | OFFSIDES | ||
| 660 | Allergic pharyngitis | OFFSIDES | ||
| 661 | Alveolitis | OFFSIDES | ||
| 662 | Anemia, Megaloblastic | 6130274 | CTD | |
| 663 | Antithrombin III decreased | OFFSIDES | ||
| 664 | Aortic bruit | OFFSIDES | ||
| 665 | Aphthous Stomatitis | OFFSIDES SIDER | ||
| 666 | Application site warmth | Canada Vigilance: 1 | Canada Vigilance | |
| 667 | Arteriosclerosis | OFFSIDES | ||
| 668 | Arteriovenous fistula thrombosis | OFFSIDES | ||
| 669 | Arthropathy | OFFSIDES | ||
| 670 | Aseptic Meningitis | OFFSIDES | ||
| 671 | Atelectasis | OFFSIDES | ||
| 672 | Atrial Flutter | OFFSIDES | ||
| 673 | Atrial bigeminy | OFFSIDES | ||
| 674 | Atrial tachycardia | Canada Vigilance: 1 | Canada Vigilance OFFSIDES | |
| 675 | Auditory and visual hallucinations | SIDER | ||
| 676 | Aura | OFFSIDES | ||
| 677 | Autoimmune hepatitis | OFFSIDES | ||
| 678 | Bacterial Infections | 12669766 | CTD | |
| 679 | Band neutrophil percentage decreased | OFFSIDES | ||
| 680 | Basal cell carcinoma | OFFSIDES | ||
| 681 | Bile duct necrosis | OFFSIDES | ||
| 682 | Biliary Dyskinesia | OFFSIDES | ||
| 683 | Biliary cancer metastatic | OFFSIDES | ||
| 684 | Biopsy bone marrow abnormal | OFFSIDES | ||
| 685 | Biopsy endometrium abnormal | OFFSIDES | ||
| 686 | Bipolar Disorder | 7969690 | CTD | |
| 687 | Bladder Diverticulum | OFFSIDES | ||
| 688 | Blepharitis | SIDER | ||
| 689 | Blood 1,25-dihydroxycholecalciferol decreased | OFFSIDES | ||
| 690 | Blood Glucose | OFFSIDES | ||
| 691 | Blood albumin decreased | OFFSIDES | ||
| 692 | Blood and lymphatic system disorders | SIDER | ||
| 693 | Blood chloride decreased | OFFSIDES | ||
| 694 | Blood cholesterol | OFFSIDES | ||
| 695 | Blood magnesium increased | OFFSIDES | ||
| 696 | Blood sodium increased | OFFSIDES | ||
| 697 | Blood sodium | OFFSIDES | ||
| 698 | Blood uric acid | OFFSIDES | ||
| 699 | Bone lesion | OFFSIDES | ||
| 700 | Bone marrow depression | OFFSIDES | ||
| 701 | Breast Cyst | OFFSIDES | ||
| 702 | Bronchiolitis | OFFSIDES | ||
| 703 | Bronchitis | OFFSIDES | ||
| 704 | Bronchoalveolar Lavage | OFFSIDES | ||
| 705 | Bronchoalveolar lavage abnormal | OFFSIDES | ||
| 706 | Calciphylaxis | OFFSIDES | ||
| 707 | Cancer Pain | OFFSIDES | ||
| 708 | Cardiac Tamponade | OFFSIDES SIDER | ||
| 709 | Cardiovascular insufficiency | OFFSIDES | ||
| 710 | Carotidynia | OFFSIDES | ||
| 711 | Cataract operation | OFFSIDES | ||
| 712 | Central Nervous System Infection | OFFSIDES | ||
| 713 | Cerebral cyst | OFFSIDES | ||
| 714 | Chemical and Drug Induced Liver Injury | 11214960 24085192 | CTD | |
| 715 | Choking sensation | OFFSIDES | ||
| 716 | Cholangiolitis | OFFSIDES | ||
| 717 | Chorea | 2843139 | CTD | |
| 718 | Choroidal Detachment | OFFSIDES | ||
| 719 | Chronic Obstructive Airway Disease | OFFSIDES | ||
| 720 | Chronic sinusitis | OFFSIDES | ||
| 721 | Clostridium colitis | OFFSIDES | ||
| 722 | Clostridium difficile colitis | OFFSIDES | ||
| 723 | Compression fracture | OFFSIDES | ||
| 724 | Confusion |
2396095
4062110 7571352 7973922 8038467 8228796 8322628 8559507 8671884 8810856 8825003 9496746 11908272 12799156 14658398 15247861 16854507 | CTD | |
| 725 | Creatinine increased | SIDER | ||
| 726 | Cytomegalovirus Infections | 2837588 3030175 7947045 | CTD | |
| 727 | Cytomegalovirus antibody positive | OFFSIDES | ||
| 728 | Cytomegalovirus test positive | OFFSIDES | ||
| 729 | Debridement | OFFSIDES | ||
| 730 | Demyelination | OFFSIDES | ||
| 731 | Dental Fistula | OFFSIDES | ||
| 732 | Dental caries | OFFSIDES | ||
| 733 | Depressive disorder | 3371192 3711686 | CTD | |
| 734 | Diarrhea | OFFSIDES | ||
| 735 | Diffuse Large B-Cell Lymphoma | OFFSIDES | ||
| 736 | Dilatation intrahepatic duct acquired | OFFSIDES | ||
| 737 | Distress gastrointestinal | SIDER | ||
| 738 | Diverticulitis | OFFSIDES | ||
| 739 | Diverticulosis | OFFSIDES | ||
| 740 | Endocarditis | OFFSIDES | ||
| 741 | Endodontic procedure | OFFSIDES | ||
| 742 | Enterococcal infection | OFFSIDES | ||
| 743 | Enterocutaneous Fistula | OFFSIDES | ||
| 744 | Episcleritis | OFFSIDES | ||
| 745 | Epstein-Barr virus antibody positive | OFFSIDES | ||
| 746 | Epstein-Barr virus associated lymphoproliferative disorder | OFFSIDES | ||
| 747 | Escherichia infection | OFFSIDES | ||
| 748 | Escherichia urinary tract infection | OFFSIDES | ||
| 749 | Eye laser surgery | OFFSIDES | ||
| 750 | Facial Nerve Diseases | 19278487 | CTD | |
| 751 | Febrile infection | OFFSIDES | ||
| 752 | Folliculitis | OFFSIDES | ||
| 753 | Foreign body trauma | OFFSIDES | ||
| 754 | Fungus serology test positive | OFFSIDES | ||
| 755 | Genital erosion | OFFSIDES | ||
| 756 | Gingival Hypertrophy | OFFSIDES | ||
| 757 | Globulinuria | OFFSIDES | ||
| 758 | Goiter | OFFSIDES | ||
| 759 | Granuloma | OFFSIDES | ||
| 760 | Growth failure | Canada Vigilance: 1 | Canada Vigilance | |
| 761 | Haematotoxicity | OFFSIDES | ||
| 762 | Hallucinations | CTD | ||
| 763 | Heparin-induced thrombocytopenia | OFFSIDES | ||
| 764 | Hepatitis C | OFFSIDES | ||
| 765 | Herpes NOS | SIDER | ||
| 766 | Herpes Zoster Ophthalmicus | 14606623 | CTD | |
| 767 | Herpesviridae Infections | 2729341 3711686 | CTD | |
| 768 | Hiccough | OFFSIDES | ||
| 769 | Hydronephrosis | OFFSIDES | ||
| 770 | Hypertrophy of tongue papillae | OFFSIDES | ||
| 771 | Hypophosphatemia | 8456495 14675048 | CTD | |
| 772 | Hypoxia | OFFSIDES | ||
| 773 | Immunosuppression | OFFSIDES | ||
| 774 | Instillation site pain | SIDER | ||
| 775 | Intention tremor | OFFSIDES | ||
| 776 | Intervertebral disc disorder | OFFSIDES | ||
| 777 | Keratitis sicca | OFFSIDES | ||
| 778 | Keratomileusis | OFFSIDES | ||
| 779 | Kidney Diseases | 11532999 | CTD | |
| 780 | Kidney Failure, Chronic | 14606623 16138435 | CTD | |
| 781 | Kidney Failure | OFFSIDES | ||
| 782 | Klebsiella sepsis | OFFSIDES | ||
| 783 | Large intestine perforation | OFFSIDES | ||
| 784 | Leukoencephalopathy | OFFSIDES | ||
| 785 | Leukopenia neonatal | OFFSIDES | ||
| 786 | Life expectancy shortened | OFFSIDES | ||
| 787 | Lightheadedness | SIDER | ||
| 788 | Limb operation | OFFSIDES | ||
| 789 | Lipase | OFFSIDES | ||
| 790 | Liver transplant rejection | OFFSIDES | ||
| 791 | Loose tooth | OFFSIDES | ||
| 792 | Lower respiratory tract infection fungal | OFFSIDES | ||
| 793 | Lung hyperinflation | OFFSIDES | ||
| 794 | Lung infection pseudomonal | OFFSIDES | ||
| 795 | Lymphoma | OFFSIDES | ||
| 796 | Mastication disorder | OFFSIDES | ||
| 797 | Memory Disorders | 7571352 17651180 | CTD | |
| 798 | Meningoencephalitis | 1476483 10615548 16854507 | CTD | |
| 799 | Metrorrhagia | Canada Vigilance: 1 | Canada Vigilance | |
| 800 | Mucosal erosion | OFFSIDES | ||
| 801 | Multiple Myeloma | OFFSIDES | ||
| 802 | Muscle strain | OFFSIDES | ||
| 803 | Mycobacterium avium complex immune restoration disease | OFFSIDES | ||
| 804 | Myelodysplasia | OFFSIDES | ||
| 805 | Nephritis, Interstitial | 2080005 3376977 | CTD | |
| 806 | Neural Tube Defects | 1810578 | CTD | |
| 807 | Neurobehavioral Manifestations | 8213806 | CTD | |
| 808 | Neurologic Manifestations | CTD | ||
| 809 | Neurologic reaction | SIDER | ||
| 810 | Neurotoxicity Syndromes | CTD | ||
| 811 | Nocturia | OFFSIDES | ||
| 812 | Oral infection | OFFSIDES | ||
| 813 | Oropharyngeal spasm | OFFSIDES | ||
| 814 | Osteolysis | OFFSIDES | ||
| 815 | Osteomyelitis | OFFSIDES | ||
| 816 | Osteopenia | OFFSIDES | ||
| 817 | Pars Planitis | SIDER | ||
| 818 | Pelvic abscess | OFFSIDES | ||
| 819 | Periodontitis | OFFSIDES | ||
| 820 | Physical disability | OFFSIDES | ||
| 821 | Plasmacytoma | OFFSIDES | ||
| 822 | Platelet count abnormal | OFFSIDES | ||
| 823 | Pneumococcal sepsis | OFFSIDES | ||
| 824 | Pneumocystis jiroveci pneumonia | OFFSIDES | ||
| 825 | Portal Vein Thrombosis | OFFSIDES | ||
| 826 | Portal vein stenosis | OFFSIDES | ||
| 827 | Posterior Leukoencephalopathy Syndrome | 16107379 | CTD | |
| 828 | Product complaint | Canada Vigilance: 1 | Canada Vigilance | |
| 829 | Productive Cough | OFFSIDES | ||
| 830 | Pseudomonal sepsis | OFFSIDES | ||
| 831 | Psychomotor Agitation | 8228796 | CTD | |
| 832 | Pulmonary Infarction | OFFSIDES | ||
| 833 | Pulmonary congestion | OFFSIDES | ||
| 834 | Purpura Fulminans | SIDER | ||
| 835 | Quality of life decreased | OFFSIDES | ||
| 836 | Radicular pain | OFFSIDES | ||
| 837 | Renal Insufficiency | CTD | ||
| 838 | Respiratory tract infection fungal | OFFSIDES | ||
| 839 | Retinal Necrosis Syndrome, Acute | 17406046 19278487 | CTD | |
| 840 | Retinal infarction | OFFSIDES | ||
| 841 | Seizures | 8038467 14658398 19589454 | CTD | |
| 842 | Shoulder Pain | OFFSIDES | ||
| 843 | Sinus polyp | OFFSIDES | ||
| 844 | Skin Diseases, Vesiculobullous | 3510331 | CTD | |
| 845 | Sleep Initiation and Maintenance Disorders | 8825003 | CTD | |
| 846 | Soft Tissue Infection | OFFSIDES | ||
| 847 | Soft tissue inflammation | OFFSIDES | ||
| 848 | Splenectomy | OFFSIDES | ||
| 849 | Splenic abscess | OFFSIDES | ||
| 850 | Squamous cell carcinoma of skin | OFFSIDES | ||
| 851 | Stem cell transplant | OFFSIDES | ||
| 852 | Superficial punctate keratopathy | SIDER | ||
| 853 | Synovial Cyst | OFFSIDES | ||
| 854 | Tension Headache | OFFSIDES | ||
| 855 | Tooth Extraction | OFFSIDES | ||
| 856 | Toxoplasmosis | OFFSIDES | ||
| 857 | Tracheobronchitis viral | OFFSIDES | ||
| 858 | Tracheobronchitis | OFFSIDES | ||
| 859 | Transfusion Reaction | OFFSIDES | ||
| 860 | Umbilical hernia | OFFSIDES | ||
| 861 | Urolithiasis | 11895069 | CTD | |
| 862 | Uveitis | SIDER | ||
| 863 | Vascular calcification | OFFSIDES | ||
| 864 | Viral DNA test positive | OFFSIDES | ||
| 865 | Viral pharyngitis | OFFSIDES | ||
| 866 | Weight Gain | OFFSIDES | ||
| 867 | West Nile viral infection | OFFSIDES | ||
| 868 | Wound Complication | OFFSIDES | ||
| 869 | Wound dehiscence | OFFSIDES | ||
| 870 | prostatitis | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.